Publications

Filter by: Practice Areas Life Sciences, Central and Eastern Europe

Practice Areas

Date

Start year

Start Month

　～　

End year

End Month

Keywords

Results 1～20 of 44

2023.10

Publication of article on due diligence case studies in current company practice

Articles
- Jumpei NAGAOKA
2023.9

The Pharmaceutical Intellectual Property and Competition Law Review - Edition 4: Japan

Articles
- Yoko KASAI
- Junko WAKABAYASHI
2022.10

Interview: The Road to Addressing Economic Security Risks (Part II)

Transcripts of lectures
- Yuki Sakurada
2022.10

Article: 50 Q&As about the Economic Security Promotion Act

Articles
- Yuki Sakurada
2022.10

Health Care M&A Transactions in Japan

Articles
2022.9

Getting the Deal Through - Pharma & Medical Device Regulation 2023, Japan chapter

Books
- Gai MATSUSHITA
2022.9

Interview: The Road to Addressing Economic Security Risks (Part I)

Transcripts of lectures
- Yuki Sakurada
2022.9

Article: 50 Q&As about the Economic Security Promotion Act

Articles
- Yuki Sakurada
2022.8

Upcoming Control for the Safe Usage of Cannabis and Hemp

Articles
- Nuttaros TANGPRASITTI
- Sattapat SURADECHA
2022.8

The Pharma Legal Handbook: Japan

Articles
2022.4

Establishing a legal compliance system to secure the trust of healthcare companies - based on investigations of actual cases of non - compliance by pharmaceutical companies

Articles
- Alisa INUZUKA
- Michiko KINOSHITA
2022.3

New Classification of Narcotics Under Category 5 of the Narcotics Code

Articles
- Nuttaros TANGPRASITTI
2021.5

Legalization of Hemp-Related Business in Thailand

Articles
- Jirapong SRIWAT
2021.5

Transaction Structures for Private Company M&A

Articles
2021.2

The CPTPP investment chapter and potential implications for the UK’s accession

Articles
- Lars MARKERT
- Shimpei ISHIDO
2020.9

Corpus Juris Series - Personal Information Protection Legislation (Global)

Books
- Yo Ota (Author-Editor)
- Hitomi Iwase (Author-Editor)
- Hiroko Shibata (Author)
2020.9

Summary of UK High Court Case regarding Force Majeure and Indirect Damage (2 Entertain Video Ltd v Sony DADC Europe Ltd (2020))

Articles
- Shogo EGUCHI
2020.7

The International Comparative Legal Guide to Pharmaceutical Advertising 2020: Japan

Articles
- Yoko KASAI
- Takuya MIMA
2019.8

The Pharma Legal Handbook: Japan

Articles
- Mariko MIMURA
- Haruhi ABE
2019.6

The International Comparative Legal Guide to Pharmaceutical Advertising 2019: Japan

Articles
- Yoko KASAI
- Takuya MIMA

Locations

Publications

Select Practice Areas

戻る Practice

Publication of article on due diligence case studies in current company practice

The Pharmaceutical Intellectual Property and Competition Law Review - Edition 4: Japan

Interview: The Road to Addressing Economic Security Risks (Part II)

Article: 50 Q&As about the Economic Security Promotion Act

Health Care M&A Transactions in Japan

Getting the Deal Through - Pharma & Medical Device Regulation 2023, Japan chapter

Interview: The Road to Addressing Economic Security Risks (Part I)

Article: 50 Q&As about the Economic Security Promotion Act

Upcoming Control for the Safe Usage of Cannabis and Hemp

The Pharma Legal Handbook: Japan

Establishing a legal compliance system to secure the trust of healthcare companies - based on investigations of actual cases of non - compliance by pharmaceutical companies

New Classification of Narcotics Under Category 5 of the Narcotics Code

Legalization of Hemp-Related Business in Thailand

Transaction Structures for Private Company M&A

The CPTPP investment chapter and potential implications for the UK’s accession

Corpus Juris Series - Personal Information Protection Legislation (Global)

Summary of UK High Court Case regarding Force Majeure and Indirect Damage (2 Entertain Video Ltd v Sony DADC Europe Ltd (2020))

The International Comparative Legal Guide to Pharmaceutical Advertising 2020: Japan

The Pharma Legal Handbook: Japan

The International Comparative Legal Guide to Pharmaceutical Advertising 2019: Japan

Practice